Cargando…

Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes

AIMS: Prolonged QT interval is associated with cardiac arrhythmias and sudden death. The present study determined the prevalence of prolonged QT interval and QT dispersion and defined their clinical and metabolic predictors in patients with type 2 diabetes. METHODS: Cross-sectional study included 50...

Descripción completa

Detalles Bibliográficos
Autores principales: Ninkovic, Vladan M., Ninkovic, Srdjan M., Miloradovic, Vanja, Stanojevic, Dejan, Babic, Marijana, Giga, Vojislav, Dobric, Milan, Trenell, Michael I., Lalic, Nebojsa, Seferovic, Petar M., Jakovljevic, Djordje G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014905/
https://www.ncbi.nlm.nih.gov/pubmed/27107571
http://dx.doi.org/10.1007/s00592-016-0864-y
_version_ 1782452342265741312
author Ninkovic, Vladan M.
Ninkovic, Srdjan M.
Miloradovic, Vanja
Stanojevic, Dejan
Babic, Marijana
Giga, Vojislav
Dobric, Milan
Trenell, Michael I.
Lalic, Nebojsa
Seferovic, Petar M.
Jakovljevic, Djordje G.
author_facet Ninkovic, Vladan M.
Ninkovic, Srdjan M.
Miloradovic, Vanja
Stanojevic, Dejan
Babic, Marijana
Giga, Vojislav
Dobric, Milan
Trenell, Michael I.
Lalic, Nebojsa
Seferovic, Petar M.
Jakovljevic, Djordje G.
author_sort Ninkovic, Vladan M.
collection PubMed
description AIMS: Prolonged QT interval is associated with cardiac arrhythmias and sudden death. The present study determined the prevalence of prolonged QT interval and QT dispersion and defined their clinical and metabolic predictors in patients with type 2 diabetes. METHODS: Cross-sectional study included 501 patients with type 2 diabetes. A standard 12-lead electrocardiogram was recorded. QT corrected for heart rate (QTc) >440 ms and QT dispersion (QTd) >80 ms were considered abnormally prolonged. QTc ≥ 500 ms was considered a high-risk QTc prolongation. Demographic, clinical and laboratory data were collected. Independent risk factors for prolonged QTc and QTd were assessed using logistic regression analysis. RESULTS: Prevalence of QTc > 440 ms and QTd > 80 ms were 44.1 and 3.6 %, respectively. Prevalence of high-risk QTc (≥500 ms) was 2 % only. Independent risk factors for QTc prolongation >440 ms were mean blood glucose (β = 2.192, p < 0.001), treatment with sulphonylurea (β = 5.198, p = 0.027), female gender (β = 8.844, p < 0.001), and coronary heart disease (β = 8.636, p = 0.001). Independent risk factors for QTc ≥ 500 ms were coronary heart disease (β = 4.134, p < 0.001) and mean blood glucose level (β = 1.735, p < 0.001). The independent risk factor for prolonged QTd was only coronary heart disease (β = 5.354, p < 0.001). CONCLUSIONS: Although the prevalence of prolonged QTc > 440 ms is significant, the prevalence of high-risk QTc (≥500 ms) and QTd > 80 ms is very low in patients with type 2 diabetes. Hyperglycaemia and coronary heart disease are strong predictors of high-risk QTc.
format Online
Article
Text
id pubmed-5014905
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-50149052016-09-19 Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes Ninkovic, Vladan M. Ninkovic, Srdjan M. Miloradovic, Vanja Stanojevic, Dejan Babic, Marijana Giga, Vojislav Dobric, Milan Trenell, Michael I. Lalic, Nebojsa Seferovic, Petar M. Jakovljevic, Djordje G. Acta Diabetol Original Article AIMS: Prolonged QT interval is associated with cardiac arrhythmias and sudden death. The present study determined the prevalence of prolonged QT interval and QT dispersion and defined their clinical and metabolic predictors in patients with type 2 diabetes. METHODS: Cross-sectional study included 501 patients with type 2 diabetes. A standard 12-lead electrocardiogram was recorded. QT corrected for heart rate (QTc) >440 ms and QT dispersion (QTd) >80 ms were considered abnormally prolonged. QTc ≥ 500 ms was considered a high-risk QTc prolongation. Demographic, clinical and laboratory data were collected. Independent risk factors for prolonged QTc and QTd were assessed using logistic regression analysis. RESULTS: Prevalence of QTc > 440 ms and QTd > 80 ms were 44.1 and 3.6 %, respectively. Prevalence of high-risk QTc (≥500 ms) was 2 % only. Independent risk factors for QTc prolongation >440 ms were mean blood glucose (β = 2.192, p < 0.001), treatment with sulphonylurea (β = 5.198, p = 0.027), female gender (β = 8.844, p < 0.001), and coronary heart disease (β = 8.636, p = 0.001). Independent risk factors for QTc ≥ 500 ms were coronary heart disease (β = 4.134, p < 0.001) and mean blood glucose level (β = 1.735, p < 0.001). The independent risk factor for prolonged QTd was only coronary heart disease (β = 5.354, p < 0.001). CONCLUSIONS: Although the prevalence of prolonged QTc > 440 ms is significant, the prevalence of high-risk QTc (≥500 ms) and QTd > 80 ms is very low in patients with type 2 diabetes. Hyperglycaemia and coronary heart disease are strong predictors of high-risk QTc. Springer Milan 2016-04-23 2016 /pmc/articles/PMC5014905/ /pubmed/27107571 http://dx.doi.org/10.1007/s00592-016-0864-y Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Ninkovic, Vladan M.
Ninkovic, Srdjan M.
Miloradovic, Vanja
Stanojevic, Dejan
Babic, Marijana
Giga, Vojislav
Dobric, Milan
Trenell, Michael I.
Lalic, Nebojsa
Seferovic, Petar M.
Jakovljevic, Djordje G.
Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes
title Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes
title_full Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes
title_fullStr Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes
title_full_unstemmed Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes
title_short Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes
title_sort prevalence and risk factors for prolonged qt interval and qt dispersion in patients with type 2 diabetes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014905/
https://www.ncbi.nlm.nih.gov/pubmed/27107571
http://dx.doi.org/10.1007/s00592-016-0864-y
work_keys_str_mv AT ninkovicvladanm prevalenceandriskfactorsforprolongedqtintervalandqtdispersioninpatientswithtype2diabetes
AT ninkovicsrdjanm prevalenceandriskfactorsforprolongedqtintervalandqtdispersioninpatientswithtype2diabetes
AT miloradovicvanja prevalenceandriskfactorsforprolongedqtintervalandqtdispersioninpatientswithtype2diabetes
AT stanojevicdejan prevalenceandriskfactorsforprolongedqtintervalandqtdispersioninpatientswithtype2diabetes
AT babicmarijana prevalenceandriskfactorsforprolongedqtintervalandqtdispersioninpatientswithtype2diabetes
AT gigavojislav prevalenceandriskfactorsforprolongedqtintervalandqtdispersioninpatientswithtype2diabetes
AT dobricmilan prevalenceandriskfactorsforprolongedqtintervalandqtdispersioninpatientswithtype2diabetes
AT trenellmichaeli prevalenceandriskfactorsforprolongedqtintervalandqtdispersioninpatientswithtype2diabetes
AT lalicnebojsa prevalenceandriskfactorsforprolongedqtintervalandqtdispersioninpatientswithtype2diabetes
AT seferovicpetarm prevalenceandriskfactorsforprolongedqtintervalandqtdispersioninpatientswithtype2diabetes
AT jakovljevicdjordjeg prevalenceandriskfactorsforprolongedqtintervalandqtdispersioninpatientswithtype2diabetes